Narayana Hrudayalaya Ltd. — PPTs, 01-08-2025: Investor Presentation
**Financial Highlights:**
Narayana Health reported strong Q1 FY26 results. Consolidated operating revenues surged 15.4% YoY to ₹1,507.3 Cr, with EBITDA at ₹360.7 Cr (23.9% margin) and PAT at ₹196.1 Cr (13.0% margin). India operations revenue grew 7.8% YoY to ₹1,131.6 Cr. Net debt-to-equity remained low at 0.09 (₹343 Cr).
**Strategic Initiatives & Growth Drivers:**
The company targets 7,600+ operational beds by FY30, planning 1,535 new beds via greenfield/lease projects. Digital transformation is ongoing, significantly improving inpatient document digitization and patient app adoption. Integrated care programs continue to expand.
**Business Developments:**
Operational highlights include facility upgrades and specialized surgeries across various hospitals. The integrated care platform generated ₹13.55 Cr revenue, enhancing health insurance offerings.
**Market Position & Competitive Advantage:**
Narayana Health boasts a strong footprint with 40 facilities and 5,563 operational beds across India and Cayman Islands. Its leadership in Cardiac Sciences and Oncology, coupled with a diversified payor mix, solidifies its market standing.
**Investor Implications:**
These updates signal robust financial performance and clear strategic growth. Ambitious bed capacity expansion and digital advancements indicate positive growth potential, backed by a healthy balance sheet.
